Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaojun Wu

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Aging|April 15, 2022
Correction for: Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cellsShushi Huang, Wu Luo, Gaojun Wu, et al.
Circulation Research|February 1, 2023
USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in CardiomyocytesBozhi Ye, Hao Zhou, Yanghao Chen, et al.
Nature Communications|July 2, 2025
Cardiomyocyte-derived USP13 protects hearts from hypertrophy via deubiquitinating and stabilizing STAT1 in male miceJibo Han, Liming Lin, Zimin Fang, et al.
Theranostics|October 21, 2024
Cardiomyocyte-derived USP28 negatively regulates antioxidant response and promotes cardiac hypertrophy via deubiquitinating TRIM21Jibo Han, Liming Lin, Zimin Fang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 7, 2024
OTUD1 promotes isoprenaline- and myocardial infarction-induced heart failure by targeting PDE5A in cardiomyocytesQinyan Wang, Shiqi Liang, Jinfu Qian, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 8, 2023
Inhibition of MD2 by natural product-drived JM-9 attenuates renal inflammation and diabetic nephropathy in miceMinxiu Wang, Qianhui Zhang, Shuaijie Lou, et al.
International Immunopharmacology|September 27, 2023
Linderalactone mitigates diabetic cardiomyopathy in mice via suppressing the MAPK/ATF6 pathwayXue Han, Wenwei Zhou, Jiajia Zhang, et al.
Science Advances|June 25, 2025
Cardiomyocyte-derived YOD1 promotes pathological cardiac hypertrophy by deubiquitinating and stabilizing STAT3Bozhi Ye, Wante Lin, Yucheng Jiang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 13, 2023
Dectin-1 deficiency alleviates diabetic cardiomyopathy by attenuating macrophage-mediated inflammatory responseNa Yang, Minxiu Wang, Ke Lin, et al.
Aging|June 8, 2021
Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cellsShushi Huang, Wu Luo, Gaojun Wu, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Aging|April 15, 2022
Correction for: Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cellsShushi Huang, Wu Luo, Gaojun Wu, et al.
Circulation Research|February 1, 2023
USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in CardiomyocytesBozhi Ye, Hao Zhou, Yanghao Chen, et al.
Nature Communications|July 2, 2025
Cardiomyocyte-derived USP13 protects hearts from hypertrophy via deubiquitinating and stabilizing STAT1 in male miceJibo Han, Liming Lin, Zimin Fang, et al.
Theranostics|October 21, 2024
Cardiomyocyte-derived USP28 negatively regulates antioxidant response and promotes cardiac hypertrophy via deubiquitinating TRIM21Jibo Han, Liming Lin, Zimin Fang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 7, 2024
OTUD1 promotes isoprenaline- and myocardial infarction-induced heart failure by targeting PDE5A in cardiomyocytesQinyan Wang, Shiqi Liang, Jinfu Qian, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 8, 2023
Inhibition of MD2 by natural product-drived JM-9 attenuates renal inflammation and diabetic nephropathy in miceMinxiu Wang, Qianhui Zhang, Shuaijie Lou, et al.
International Immunopharmacology|September 27, 2023
Linderalactone mitigates diabetic cardiomyopathy in mice via suppressing the MAPK/ATF6 pathwayXue Han, Wenwei Zhou, Jiajia Zhang, et al.
Science Advances|June 25, 2025
Cardiomyocyte-derived YOD1 promotes pathological cardiac hypertrophy by deubiquitinating and stabilizing STAT3Bozhi Ye, Wante Lin, Yucheng Jiang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 13, 2023
Dectin-1 deficiency alleviates diabetic cardiomyopathy by attenuating macrophage-mediated inflammatory responseNa Yang, Minxiu Wang, Ke Lin, et al.
Aging|June 8, 2021
Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cellsShushi Huang, Wu Luo, Gaojun Wu, et al.
Pageof 7